MX9703724A - Antagonistas de bradiquinina heterociclicos con contenido en azufre, procedimiento para su preparacion y su empleo. - Google Patents

Antagonistas de bradiquinina heterociclicos con contenido en azufre, procedimiento para su preparacion y su empleo.

Info

Publication number
MX9703724A
MX9703724A MX9703724A MX9703724A MX9703724A MX 9703724 A MX9703724 A MX 9703724A MX 9703724 A MX9703724 A MX 9703724A MX 9703724 A MX9703724 A MX 9703724A MX 9703724 A MX9703724 A MX 9703724A
Authority
MX
Mexico
Prior art keywords
alkyl
aryl
preparation
equal
different
Prior art date
Application number
MX9703724A
Other languages
English (en)
Other versions
MXPA97003724A (es
Inventor
Adalbert Wagner
Holger Heitsch
Gerhard Nolken
Klaus Wirth
Bernward Scholkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of MX9703724A publication Critical patent/MX9703724A/es
Publication of MXPA97003724A publication Critical patent/MXPA97003724A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen compuestos de la formula I: en donde uno de los radicales X1, X2 o X3, representan C-O-R2 los respectivos otros X1, X2, X3 y X4 son entonces, iguales o diferentes, N o CR1; R1 y R3, iguales o diferentes, son H, halogeno, alquilo (C1-C6), O-R6, S-R6, NHR6, arilo (C6-C12), aril (C6-C12)-alquilo (C2-C3), C(O)-OR6, C(O)-H, alquenilo (C2-C5), NO2, SO3R7, CN o C(O)-NHR8, pudiendo estar alquilo, arilo y el alquenilo eventualmente sustituidos; R2 es un compuesto de la formula (II) R4 y R5, iguales o diferentes, son H, halogeno, OR6, SR6, CN o alquilo (C1-C5); R6, R7 y R8, iguales o diferentes, son H, alquilo (C1-C5), alquenilo (C3-C5), aril (C6-C12)-alquilo (C1-C3), cicloalquilo (C3-C10), cicloalquil (C3-C10)-alquilo (C1-C3), C(O)-(O)0-1-alquilo (C1-C5) o C(O)- (NH) 0-1-alquilo (C1-C5) o C(O)-(O)0-1-alquil (C1-C3)-arilo (C6-C10); R10 es -C(O)-D-E, -C(S)-D-E, -SO2-D-E o hidrogeno; D es alquendiilo (C2-C5), alcandiilo (C1-C8), -(CH2)n-Yo-(CH2)m-, cicloalcandiilo (C3-C10), cicloalquil (C3-C10)-alcandiilo (C1-C3), cicloalquendiilo (C3-C10) o cicloalquenil (C3-C10)-alcandiilo (c1-C3), que eventualmente pueden estar sustituidos; E es H, arilo (C6-C10) o heteroarilo (C1-C9), que eventualmente pueden estar sustituidos; Y es O, S o NR8; así como sus sales fisiologicamente compatibles, un procedimiento para su preparacion y su empleo como agentes curativos y terapéuticos.
MXPA/A/1997/003724A 1996-05-22 1997-05-21 Antagonistas de bradiquinina heterociclicos con contenido en azufre, procedimiento para su preparacion y su empleo MXPA97003724A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19620508.5 1996-05-22
DE19620508A DE19620508A1 (de) 1996-05-22 1996-05-22 Schwefelenthaltende heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number Publication Date
MX9703724A true MX9703724A (es) 1998-06-28
MXPA97003724A MXPA97003724A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
HU9700914D0 (en) 1997-07-28
CZ154797A3 (en) 1997-12-17
JP4125803B2 (ja) 2008-07-30
DE19620508A1 (de) 1997-11-27
DE59710874D1 (de) 2003-11-27
AU2351097A (en) 1997-11-27
JPH1067762A (ja) 1998-03-10
EP0808838B1 (de) 2003-10-22
BR9703370A (pt) 1998-09-22
NO972312L (no) 1997-11-24
TR199700391A2 (xx) 1997-12-21
ES2205086T3 (es) 2004-05-01
HUP9700914A3 (en) 1999-05-28
ID16952A (id) 1997-11-27
HRP970279A2 (en) 1998-04-30
SK63197A3 (en) 1997-12-10
HUP9700914A2 (hu) 1998-11-30
CN1169992A (zh) 1998-01-14
EP0808838A1 (de) 1997-11-26
ZA974416B (en) 1997-11-24
IL120863A0 (en) 1997-09-30
KR970074781A (ko) 1997-12-10
US5834500A (en) 1998-11-10
NO972312D0 (no) 1997-05-21
PL320105A1 (en) 1997-11-24
CA2205785A1 (en) 1997-11-22
ATE252567T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
CO4770975A1 (es) Derivados de quinazolina sustituidos
HUT76064A (en) Fused pyrrolecarboxanilides
DE69532817D1 (de) Verwendung von pyrazole verbindungen zur behandlung von glomerulonephritis, krebs, atherosklerose oder restenose
ES2191484T3 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
DE69930947D1 (de) Piperazin-4-phenyl-derivate als inhibitoren der wechselwirkung zwischen mdm2 und mdm2
DE69920496D1 (de) Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress
DE69712490D1 (de) Isoquinoline als schmerzmittel
NO951968D0 (no) 11,21-bisfenyl-19-norpregnan-derivater
DK471586A (da) 3-vinyl- og 3-ethynyl-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
NO954576D0 (no) AMPA antagonister og en fremgangsmåte til behandling med dem
MX9703724A (es) Antagonistas de bradiquinina heterociclicos con contenido en azufre, procedimiento para su preparacion y su empleo.
TR200201600T2 (tr) Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar.
DE3666038D1 (de) 1-aryl-4-nitropyrazoles
DE60103857D1 (de) Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose
DK104488A (da) Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
TH30776A (th) ขบวนการที่ใช้สำหรับเตรียมและใช้ตัวต่อต้านบราดิไคนินที่เป็นเฮเทอโรไซคลิก ซึ่งมีซัลเฟอร์